{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:46:44Z","timestamp":1792802804274,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2158"],"award-info":[{"award-number":["GRK2158"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2578"],"award-info":[{"award-number":["GRK2578"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2158"],"award-info":[{"award-number":["GRK2158"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2578"],"award-info":[{"award-number":["GRK2578"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2158"],"award-info":[{"award-number":["GRK2158"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2158"],"award-info":[{"award-number":["GRK2158"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2578"],"award-info":[{"award-number":["GRK2578"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2158"],"award-info":[{"award-number":["GRK2158"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Meriolin derivatives represent a new class of kinase inhibitors with a pronounced cytotoxic potential. Here, we investigated a newly synthesized meriolin derivative (termed meriolin 16) that displayed a strong apoptotic potential in Jurkat leukemia and Ramos lymphoma cells. Meriolin 16 induced apoptosis in rapid kinetics (within 2\u20133\u2009h) and more potently (IC\n                    <jats:sub>50<\/jats:sub>\n                    : 50\u2009nM) than the previously described derivatives meriolin 31 and 36 [1]. Exposure of Ramos cells to meriolin 16, 31, or 36 for 5\u2009min was sufficient to trigger severe and irreversible cytotoxicity. Apoptosis induction by all three meriolin derivatives was independent of death receptor signaling but required caspase-9 and Apaf-1 as central mediators of the mitochondrial death pathway. Meriolin-induced mitochondrial toxicity was demonstrated by disruption of the mitochondrial membrane potential (\u0394\u03a8m), mitochondrial release of proapoptotic Smac, processing of the dynamin-like GTPase OPA1, and subsequent fragmentation of mitochondria. Remarkably, all meriolin derivatives were able to activate the mitochondrial death pathway in Jurkat cells, even in the presence of the antiapoptotic Bcl-2 protein. In addition, meriolins were capable of inducing cell death in imatinib-resistant K562 and KCL22 chronic myeloid leukemia cells as well as in cisplatin-resistant J82 urothelial carcinoma and 2102EP germ cell tumor cells. Given the frequent inactivation of the mitochondrial apoptosis pathway by tumor cells, such as through overexpression of antiapoptotic Bcl-2, meriolin derivatives emerge as promising therapeutic agents for overcoming treatment resistance.\n                  <\/jats:p>","DOI":"10.1038\/s41420-024-01901-y","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:01:50Z","timestamp":1709974910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-9800","authenticated-orcid":false,"given":"Laura","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-1885","authenticated-orcid":false,"given":"Ilka","family":"Lechtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Drie\u00dfen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0996-5717","authenticated-orcid":false,"given":"Hector","family":"Flores-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretha A.","family":"Skowron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1485-7453","authenticated-orcid":false,"given":"Julia","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6519-1395","authenticated-orcid":false,"given":"Karina S.","family":"Krings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya R.","family":"Llewellyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0048-2279","authenticated-orcid":false,"given":"Christoph","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4167-7806","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanil","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nettersheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3894-5945","authenticated-orcid":false,"given":"Ana J.","family":"Garc\u00eda-S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-724X","authenticated-orcid":false,"given":"Thomas J. J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5236-942X","authenticated-orcid":false,"given":"Sebastian","family":"Wesselborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"key":"1901_CR1","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1016\/j.bmc.2019.06.029","volume":"27","author":"D Drie\u00dfen","year":"2019","unstructured":"Drie\u00dfen D, Stuhldreier F, Frank A, Stark H, Wesselborg S, Stork B, et al. Novel meriolin derivatives as rapid apoptosis inducers. Bioorg Med Chem. 2019;27:3463\u20138.","journal-title":"Bioorg Med Chem"},{"key":"1901_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrc2559","volume":"9","author":"J Zhang","year":"2009","unstructured":"Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 2009;9:28\u201339.","journal-title":"Nat Rev Cancer"},{"key":"1901_CR3","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1172\/JCI76094","volume":"125","author":"S Gross","year":"2015","unstructured":"Gross S, Rahal R, Stransky N, Lengauer C, Hoeflich KP. Targeting cancer with kinase inhibitors. J Clin Invest. 2015;125:1780\u20139.","journal-title":"J Clin Invest"},{"key":"1901_CR4","first-page":"1913","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhang L, Hei R, Li X, Cai H, Wu X, et al. CDK inhibitors in cancer therapy, an overview of recent development. Am J Cancer Res. 2021;11:1913\u201335.","journal-title":"Am J Cancer Res"},{"key":"1901_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12094-021-02688-5","volume":"24","author":"E Panagiotou","year":"2022","unstructured":"Panagiotou E, Gomatou G, Trontzas IP, Syrigos N, Kotteas E. Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials. Clin Transl Oncol. 2022;24:161\u201392.","journal-title":"Clin Transl Oncol"},{"key":"1901_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","volume":"20","author":"MM Attwood","year":"2021","unstructured":"Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schioth HB. Trends in kinase drug discovery: targets, indications and inhibitor design. Nat Rev Drug Discov. 2021;20:839\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"1901_CR7","doi-asserted-by":"publisher","first-page":"8325","DOI":"10.1158\/0008-5472.CAN-07-1826","volume":"67","author":"K Bettayeb","year":"2007","unstructured":"Bettayeb K, Tirado OM, Marionneau-Lambot S, Ferandin Y, Lozach O, Morris JC, et al. Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases. Cancer Res. 2007;67:8325\u201334.","journal-title":"Cancer Res"},{"key":"1901_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/molecules28030947","volume":"28","author":"M Kruppa","year":"2023","unstructured":"Kruppa M, M\u00fcller TJJ. A survey on the synthesis of variolins, meridianins, and meriolins-naturally occurring marine (aza)indole alkaloids and their semisynthetic derivatives. Molecules. 2023;28:947.","journal-title":"Molecules"},{"key":"1901_CR9","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/S0040-4020(01)00102-8","volume":"57","author":"PM Fresneda","year":"2001","unstructured":"Fresneda PM, Molina P, Bleda JA. Synthesis of the indole alkaloids meridianins from the tunicate Aplidium meridianum. Tetrahedron. 2001;57:2355\u201363.","journal-title":"Tetrahedron"},{"key":"1901_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1021\/jm700940h","volume":"51","author":"A Echalier","year":"2008","unstructured":"Echalier A, Bettayeb K, Ferandin Y, Lozach O, Clement M, Valette A, et al. Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2\/cyclin A\/meriolin complex. J Med Chem. 2008;51:737\u201351.","journal-title":"J Med Chem"},{"key":"1901_CR11","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/neuonc\/nou102","volume":"16","author":"M Jarry","year":"2014","unstructured":"Jarry M, Lecointre C, Malleval C, Desrues L, Schouft M-T, Lejoncour V, et al. Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis. Neuro Oncol. 2014;16:1484\u201398.","journal-title":"Neuro Oncol"},{"key":"1901_CR12","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.18632\/oncotarget.14689","volume":"8","author":"A Alexander","year":"2017","unstructured":"Alexander A, Karakas C, Chen X, Carey JP, Yi M, Bondy M, et al. Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. Oncotarget. 2017;8:14897\u2013911.","journal-title":"Oncotarget"},{"key":"1901_CR13","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/0008-5472.CAN-10-4086","volume":"71","author":"S Akli","year":"2011","unstructured":"Akli S, Van Pelt CS, Bui T, Meijer L, Keyomarsi K. Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E. Cancer Res. 2011;71:3377\u201386.","journal-title":"Cancer Res"},{"key":"1901_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/1573406415666190626113900","volume":"16","author":"J Mou","year":"2020","unstructured":"Mou J, Chen D, Deng Y. Inhibitors of cyclin-dependent kinase 1\/2 for anticancer treatment. Med Chem. 2020;16:307\u201325.","journal-title":"Med Chem"},{"key":"1901_CR15","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.1021\/cr300410v","volume":"113","author":"SB Bharate","year":"2013","unstructured":"Bharate SB, Sawant SD, Singh PP, Vishwakarma RA. Kinase inhibitors of marine origin. Chem Rev. 2013;113:6761\u2013815.","journal-title":"Chem Rev"},{"key":"1901_CR16","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3390\/ijms22062806","volume":"22","author":"P Lukasik","year":"2021","unstructured":"Lukasik P, Baranowska-Bosiacka I, Kulczycka K, Gutowska I. Inhibitors of cyclin-dependent kinases: types and their mechanism of action. Int J Mol Sci. 2021;22:2806.","journal-title":"Int J Mol Sci"},{"key":"1901_CR17","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1016\/j.bmc.2014.07.044","volume":"22","author":"D Vogt","year":"2014","unstructured":"Vogt D, Weber J, Ihlefeld K, Br\u00fcggerhoff A, Proschak E, Stark H. Design, synthesis and evaluation of 2-aminothiazole derivatives as sphingosine kinase inhibitors. Bioorg Med Chem. 2014;22:5354\u201367.","journal-title":"Bioorg Med Chem"},{"key":"1901_CR18","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1016\/j.bmcl.2016.05.005","volume":"26","author":"M Wucherer-Plietker","year":"2016","unstructured":"Wucherer-Plietker M, Merkul E, M\u00fcller TJJ, Esdar C, Kn\u00f6chel T, Heinrich T, et al. Discovery of novel 7-azaindoles as PDK1 inhibitors. Bioorg Med Chem Lett. 2016;26:3073\u201380.","journal-title":"Bioorg Med Chem Lett"},{"key":"1901_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/2212697X06666190509094514","volume":"6","author":"G Chashoo","year":"2019","unstructured":"Chashoo G, Singh U, Singh PP, Mondhe DM, Vishwakarma RA. A marine-based meriolin (3-pyrimidinylazaindole) derivative (4ab) targets PI3K\/AKT\/mTOR pathway inducing cell cycle arrest and apoptosis in Molt-4 cells. Clin Cancer Drugs. 2019;6:33\u201340.","journal-title":"Clin Cancer Drugs"},{"key":"1901_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejmech.2012.09.034","volume":"57","author":"PM Lukasik","year":"2012","unstructured":"Lukasik PM, Elabar S, Lam F, Shao H, Liu X, Abbas AY, et al. Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agents. Eur J Med Chem. 2012;57:311\u201322.","journal-title":"Eur J Med Chem"},{"key":"1901_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"1901_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1901_CR23","first-page":"491","volume":"32","author":"D Drie\u00dfen","year":"2021","unstructured":"Drie\u00dfen D, Biesen L, M\u00fcller TJJ. Sequentially catalyzed three-component Masuda-Suzuki-Sonogashira synthesis of fluorescent 2-Alkynyl-4-(7-azaindol-3-yl) pyrimidines: three palladium-catalyzed processes in a one-pot fashion. Synlett. 2021;32:491\u20136.","journal-title":"Synlett"},{"key":"1901_CR24","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1002\/ejoc.201300133","volume":"2013","author":"BOA Tasch","year":"2013","unstructured":"Tasch BOA, Antovic D, Merkul E, M\u00fcller TJJ. One\u2010pot synthesis of camalexins and 3, 3\u2032\u2010biindoles by the Masuda Borylation\u2013Suzuki arylation (MBSA) sequence. Eur J Org Chem. 2013;2013:4564\u20139.","journal-title":"Eur J Org Chem"},{"key":"1901_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apotosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271\u20139.","journal-title":"J Immunol Methods"},{"key":"1901_CR26","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1074\/jbc.M607279200","volume":"282","author":"N Taguchi","year":"2007","unstructured":"Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem. 2007;282:11521\u20139.","journal-title":"J Biol Chem"},{"key":"1901_CR27","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1242\/jcs.109769","volume":"125","author":"W Qian","year":"2012","unstructured":"Qian W, Choi S, Gibson GA, Watkins SC, Bakkenist CJ, Van Houten B. Mitochondrial hyperfusion induced by loss of the fission protein Drp1 causes ATM-dependent G2\/M arrest and aneuploidy through DNA replication stress. J Cell Sci. 2012;125:5745\u201357.","journal-title":"J Cell Sci"},{"key":"1901_CR28","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1158\/1535-7163.MCT-06-0355","volume":"5","author":"W DePinto","year":"2006","unstructured":"DePinto W, Chu X-J, Yin X, Smith M, Packman K, Goelzer P, et al. In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials. Mol Cancer Ther. 2006;5:2644\u201358.","journal-title":"Mol Cancer Ther"},{"key":"1901_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40:179\u2013204.","journal-title":"Mol Cell"},{"key":"1901_CR30","first-page":"305","volume":"22","author":"LJ Kuo","year":"2008","unstructured":"Kuo LJ, Yang LX. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. Vivo. 2008;22:305\u20139.","journal-title":"Vivo"},{"key":"1901_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/1541-7786.MCR-11-0134","volume":"10","author":"D White","year":"2012","unstructured":"White D, Rafalska-Metcalf IU, Ivanov AV, Corsinotti A, Peng H, Lee S-C, et al. The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and serine 473\/824 phosphorylation. Mol Cancer Res. 2012;10:401\u201314.","journal-title":"Mol Cancer Res"},{"key":"1901_CR32","doi-asserted-by":"publisher","first-page":"11594","DOI":"10.1158\/0008-5472.CAN-06-4138","volume":"66","author":"DE White","year":"2006","unstructured":"White DE, Negorev D, Peng H, Ivanov AV, Maul GG, Rauscher IIIFJ. KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions. Cancer Res. 2006;66:11594\u20139.","journal-title":"Cancer Res"},{"key":"1901_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bjh.14684","volume":"178","author":"M Vogler","year":"2017","unstructured":"Vogler M, Walter HS, Dyer MJS. Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment. Br J Haematol. 2017;178:364\u201379.","journal-title":"Br J Haematol"},{"key":"1901_CR34","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.immuni.2019.05.020","volume":"50","author":"N Van Opdenbosch","year":"2019","unstructured":"Van Opdenbosch N, Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity. 2019;50:1352\u201364.","journal-title":"Immunity"},{"key":"1901_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a006080","volume":"7","author":"DR Green","year":"2015","unstructured":"Green DR, Llambi F. Cell death signaling. Cold Spring Harb Perspect Biol. 2015;7:1\u201324.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1901_CR36","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0960-9822(07)00420-4","volume":"8","author":"P Juo","year":"1998","unstructured":"Juo P, Kuo CJ, Yuan J, Blenis J. Essential requirement for caspase-8\/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol. 1998;8:1001\u20138.","journal-title":"Curr Biol"},{"key":"1901_CR37","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1096\/fj.10-177527","volume":"25","author":"J Manns","year":"2011","unstructured":"Manns J, Daubrawa M, Driessen S, Paasch F, Hoffmann N, L\u00f6ffler A, et al. Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: activation of caspase\u20109 in the absence of Apaf\u20101. FASEB J. 2011;25:3250\u201361.","journal-title":"FASEB J"},{"key":"1901_CR38","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1038\/sj.onc.1203824","volume":"19","author":"IH Engels","year":"2000","unstructured":"Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, et al. Caspase-8\/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene. 2000;19:4563\u201373.","journal-title":"Oncogene"},{"key":"1901_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35051606","volume":"409","author":"MS Soengas","year":"2001","unstructured":"Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 2001;409:207\u201311.","journal-title":"Nature"},{"key":"1901_CR40","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1242\/jcs.159186","volume":"129","author":"T MacVicar","year":"2016","unstructured":"MacVicar T, Langer T. OPA1 processing in cell death and disease \u2013 the long and short of it. J Cell Sci. 2016;129:2297\u2013306.","journal-title":"J Cell Sci"},{"key":"1901_CR41","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1152\/ajprenal.00036.2014","volume":"306","author":"X Xiao","year":"2014","unstructured":"Xiao X, Hu Y, Quir\u00f3s PM, Wei Q, L\u00f3pez-Ot\u00edn C, Dong Z. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury. Am J Physiol Ren Physiol. 2014;306:1318\u201326.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1901_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood-2017-10-810986","volume":"132","author":"S Bhatia","year":"2018","unstructured":"Bhatia S, Diedrich D, Frieg B, Ahlert H, Stein S, Bopp B, et al. Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response. Blood. 2018;132:307\u201320.","journal-title":"Blood"},{"key":"1901_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms20010021","volume":"20","author":"C Oing","year":"2018","unstructured":"Oing C, Verem I, Mansour WY, Bokemeyer C, Dyshlovoy S, Honecker F. 5-Azacitidine exerts prolonged pro-apoptotic effects and overcomes cisplatin-resistance in non-seminomatous germ cell tumor cells. Int J Mol Sci. 2018;20:21.","journal-title":"Int J Mol Sci"},{"key":"1901_CR44","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1093\/annonc\/mdr026","volume":"22","author":"K Oechsle","year":"2011","unstructured":"Oechsle K, Honecker F, Cheng T, Mayer F, Czaykowski P, Winquist E, et al. Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group\/German Testicular Cancer Study Group cooperative study. Ann Oncol. 2011;22:2654\u201360.","journal-title":"Ann Oncol"},{"key":"1901_CR45","doi-asserted-by":"publisher","first-page":"41320","DOI":"10.18632\/oncotarget.9321","volume":"7","author":"A H\u00f6hn","year":"2016","unstructured":"H\u00f6hn A, Kr\u00fcger K, Skowron MA, Bormann S, Schumacher L, Schulz WA, et al. Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells. Oncotarget. 2016;7:41320\u201335.","journal-title":"Oncotarget"},{"key":"1901_CR46","doi-asserted-by":"crossref","unstructured":"Bernardi P, Di F. The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection. J Mol Cell Cardiol. 2014;78:100\u20136.","DOI":"10.1016\/j.yjmcc.2014.09.023"},{"key":"1901_CR47","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1016\/j.bmcl.2006.06.073","volume":"16","author":"S Huang","year":"2006","unstructured":"Huang S, Li R, Connolly PJ, Emanuel S, Middleton SA. Synthesis of 2-amino-4-(7-azaindol-3-yl) pyrimidines as cyclin dependent kinase 1 (CDK1) inhibitors. Bioorg Med Chem Lett. 2006;16:4818\u201321.","journal-title":"Bioorg Med Chem Lett"},{"key":"1901_CR48","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1088\/0370-1298\/68\/11\/303","volume":"68","author":"JN Murrell","year":"1955","unstructured":"Murrell JN. The electronic spectrum of aromatic molecules VI: the mesomeric effect. Proc Phys Soc. 1955;68:969.","journal-title":"Proc Phys Soc"},{"key":"1901_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/34112","volume":"391","author":"M Enari","year":"1998","unstructured":"Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;391:43\u201350.","journal-title":"Nature"},{"key":"1901_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/34214","volume":"391","author":"H Sakahira","year":"1998","unstructured":"Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 1998;391:96\u20139.","journal-title":"Nature"},{"key":"1901_CR51","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1158\/1078-0432.CCR-19-1853","volume":"26","author":"J Cidado","year":"2020","unstructured":"Cidado J, Boiko S, Proia T, Ferguson D, Criscione SW, San Martin M, et al. AZD4573 is a highly selective CDK9 inhibitor that suppresses MCL-1 and induces apoptosis in hematologic cancer cells. Clin Cancer Res. 2020;26:922\u201334.","journal-title":"Clin Cancer Res"},{"key":"1901_CR52","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1158\/0008-5472.CAN-15-1070","volume":"76","author":"A Baker","year":"2016","unstructured":"Baker A, Gregory GP, Verbrugge I, Kats L, Hilton JJ, Vidacs E, et al. The CDK9 inhibitor dinaciclib exerts potent apoptotic and antitumor effects in preclinical models of MLL-rearranged acute myeloid leukemia. Cancer Res. 2016;76:1158\u201369.","journal-title":"Cancer Res"},{"key":"1901_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.66","volume":"2","author":"G Polier","year":"2011","unstructured":"Polier G, Ding J, Konkimalla B, Eick D, Ribeiro N, K\u00f6hler R, et al. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis. 2011;2:e182","journal-title":"Cell Death Dis"},{"key":"1901_CR54","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1101\/gad.1304105","volume":"19","author":"SN Willis","year":"2005","unstructured":"Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005;19:1294\u2013305.","journal-title":"Genes Dev"},{"key":"1901_CR55","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/ncb3236","volume":"17","author":"H-C Chen","year":"2015","unstructured":"Chen H-C, Kanai M, Inoue-Yamauchi A, Tu H-C, Huang Y, Ren D, et al. An interconnected hierarchical model of cell death regulation by the BCL-2 family. Nat Cell Biol. 2015;17:1270\u201381.","journal-title":"Nat Cell Biol"},{"key":"1901_CR56","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1158\/1535-7163.MCT-16-0031","volume":"15","author":"RS Soderquist","year":"2016","unstructured":"Soderquist RS, Eastman A. BCL2 inhibitors as anticancer drugs: a plethora of misleading BH3 mimetics. Mol Cancer Ther. 2016;15:2011\u20137.","journal-title":"Mol Cancer Ther"},{"key":"1901_CR57","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1182\/blood.2020006785","volume":"138","author":"AW Roberts","year":"2021","unstructured":"Roberts AW, Wei AH, Huang DCS. BCL2 and MCL1 inhibitors for hematologic malignancies. Blood. 2021;138:1120\u201336.","journal-title":"Blood"},{"key":"1901_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4161\/auto.1.1.1495","volume":"1","author":"ETW Bampton","year":"2005","unstructured":"Bampton ETW, Goemans CG, Niranjan D, Mizushima N, Tolkovsky AM. The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo\/lysosomes. Autophagy. 2005;1:23\u201336.","journal-title":"Autophagy"},{"key":"1901_CR59","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1091\/mbc.e06-04-0263","volume":"18","author":"AK Samraj","year":"2007","unstructured":"Samraj AK, Sohn D, Schulze-Osthoff K, Schmitz I. Loss of caspase-9 reveals its essential role for caspase-2 activation and mitochondrial membrane depolarization. Mol Biol Cell. 2007;18:84\u201393.","journal-title":"Mol Biol Cell"},{"key":"1901_CR60","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1242\/jcs.114.23.4161","volume":"114","author":"J Rudner","year":"2001","unstructured":"Rudner J, Lepple-Wienhues A, Budach W, Berschauer J, Friedrich B, Wesselborg S, et al. Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J Cell Sci. 2001;114:4161\u201372.","journal-title":"J Cell Sci"},{"key":"1901_CR61","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.devcel.2010.03.014","volume":"18","author":"SWG Tait","year":"2010","unstructured":"Tait SWG, Parsons MJ, Llambi F, Bouchier-Hayes L, Connell S, Mu\u00f1oz-Pinedo C, et al. Resistance to caspase-independent cell death requires persistence of intact mitochondria. Dev Cell. 2010;18:802\u201313.","journal-title":"Dev Cell"},{"key":"1901_CR62","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nmeth.3630","volume":"12","author":"PI Thakore","year":"2015","unstructured":"Thakore PI, D\u2019Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods. 2015;12:1143\u20139.","journal-title":"Nat Methods"},{"key":"1901_CR63","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M, Mandel R, Nguyen M, Trono D, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72:8463\u201371.","journal-title":"J Virol"},{"key":"1901_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-021-01223-1","volume":"14","author":"MR M\u00fcller","year":"2022","unstructured":"M\u00fcller MR, Burmeister A, Skowron MA, Stephan A, Bremmer F, Wakileh GA, et al. Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insights. Clin Epigenetics. 2022;14:1\u201322.","journal-title":"Clin Epigenetics"},{"key":"1901_CR65","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1002\/1873-3468.12384","volume":"590","author":"M Barrera","year":"2016","unstructured":"Barrera M, Koob S, Dikov D, Vogel F, Reichert AS. OPA1 functionally interacts with MIC60 but is dispensable for crista junction formation. FEBS Lett. 2016;590:3309\u201322.","journal-title":"FEBS Lett"},{"key":"1901_CR66","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41419-018-0312-8","volume":"9","author":"P B\u00f6hler","year":"2018","unstructured":"B\u00f6hler P, Stuhldreier F, Anand R, Kondadi AK, Schl\u00fctermann D, Berleth N, et al. The mycotoxin phomoxanthone A disturbs the form and function of the inner mitochondrial membrane. Cell Death Dis. 2018;9:286\u2013302.","journal-title":"Cell Death Dis"},{"key":"1901_CR67","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"1901_CR68","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1021\/np970493u","volume":"61","author":"LH Franco","year":"1998","unstructured":"Franco LH, Joff\u00e9 EBdK, Puricelli L, Tatian M, Seldes AM, Palermo JA. Indole alkaloids from the tunicate aplidium m eridianum. J Nat Prod. 1998;61:1130\u20132.","journal-title":"J Nat Prod"},{"key":"1901_CR69","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1016\/S0040-4020(01)89674-5","volume":"50","author":"G Trimurtulu","year":"1994","unstructured":"Trimurtulu G, Faulkner DJ, Perry NB, Ettouati L, Litaudon M, Blunt JW, et al. Alkaloids from the antarctic sponge Kirkpatrickia varialosa. Part 2: Variolin A and N(3\u2032)-methyl tetrahydrovariolin B. Tetrahedron. 1994;50:3993\u20134000.","journal-title":"Tetrahedron"},{"key":"1901_CR70","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1016\/S0040-4020(01)89673-3","volume":"50","author":"NB Perry","year":"1994","unstructured":"Perry NB, Ettouati L, Litaudon M, Blunt JW, Munro MHG, Parkin S, et al. Alkaloids from the antarctic sponge Kirkpatrickia varialosa.: Part 1: variolin b, a new antitumour and antiviral compound. Tetrahedron. 1994;50:3987\u201392.","journal-title":"Tetrahedron"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-024-01901-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-024-01901-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-024-01901-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T20:44:58Z","timestamp":1731530698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-024-01901-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1038\/s41420-024-01901-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3527444\/v1","asserted-by":"object"}]},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,9]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"125"}}